Cardioprotection by activation of NO/cGMP pathway after cardioplegic arrest and 8-hour storage

Annals of Thoracic Surgery

Volumn 65, Issue 5, 1998, Pages 1303-1309

  Ali, Imtiaz S ^a   Gandhi, Manoj ^a   Finegan, Barry A ^a   Koshal, Arvind ^a   Clanachan, Alexander S ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; ENZYME INHIBITOR; NITRIC OXIDE; NITROPRUSSIDE SODIUM; ST THOMAS HOSPITAL SOLUTION;

ANIMAL TISSUE; ARTICLE; CARDIOPLEGIA; CRYOPRESERVATION; HEART; HEART LEFT VENTRICLE; HEART PRESERVATION; HEART PROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BICARBONATES; CALCIUM CHLORIDE; CARDIOPLEGIC SOLUTIONS; CORONARY CIRCULATION; CRYOPRESERVATION; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HEART ARREST, INDUCED; HEART TRANSPLANTATION; MAGNESIUM; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION; MYOCARDIUM; NITRIC OXIDE; NITROPRUSSIDE; OXADIAZOLES; POTASSIUM CHLORIDE; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; SODIUM CHLORIDE; VASODILATOR AGENTS; VENTRICULAR FUNCTION, LEFT;

EID: 0032076586     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(98)00182-9     Document Type: Article

References (24)

1. 1. Hauptman PJ, Aranki S, Mudge GH Jr, Couper GS, Loh E. Early cardiac allograft failure after orthotopic heart transplantation. Am Heart J 1994;127:179-86.
2. 2. Lefer AM. Attenuation of myocardial ischemia-reperfusion injury with nitric oxide replacement therapy. Ann Thorac Surg 1995;60:847-51.
3. 3. Nakanishi K, Zhao ZQ, Vinten-Johansen J, Hudspeth DA, McGee DS, Hammon JW Jr. Blood cardioplegia enhanced with nitric oxide donor SPM-5185 counteracts postischemic endothelial and ventricular dysfunction. J Thorac Cardiovasc Surg 1995;109:1146-54.
4. 4. Pinsky DJ, Oz MC, Koga S, et al. Cardiac preservation is enhanced in a heterotopic rat transplant model by supplementing the nitric oxide pathway. J Clin Invest 1994;93: 2291-7.
5. 5. Lefer AM. Nitric oxide: nature's naturally occurring leucocyte inhibitor. Circulation 1997;95:553-4.
6. 6. Grocott-Mason R, Fort S, Lewis MJ, Shah AM. Myocardial relaxant effect of exogenous nitric oxide in isolated ejecting hearts. Am J Physiol 1994;266:H1699-705.
7. 7. Konorev EA, Tarpey MM, Joseph J, Baker JE, Kalyanaraman B. S-nitrosoglutathione improves functional recovery in the isolated rat heart after cardioplegic ischemic arrest: evidence for a cardioprotective effect of nitric oxide. J Pharmacol Exp Ther 1995;274:200-6.
8. 8. Lopaschuk GD, Collins-Nakai R, Olley PM, et al. Plasma fatty acid levels in infants and adults after myocardial ischemia. Am Heart J 1994;128:61-7.
9. 9. Lopaschuk GD, Belke DB, Gamble J, Itoi T, Schonekess BO. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta 1994;1213:263-76.
10. 10. Richard V, Blanc T, Kaeffer N, Tron C, Thuillez C. Myocardial and coronary endothelial protective effects of acetylcholine after myocardial ischaemia and reperfusion in rats: role of nitric oxide. Br J Pharmacol 1995;115:1532-8.
11. 11. Beresewicz A, Karwatowska-Prokopczuk E, Lewartowski B, Cedro-Ceremuazynska K. A protective role of nitric oxide in isolated ischaemic/reperfused rat heart. Cardiovasc Res 1995;30:1001-8.
12. 12. Amrani M, Chester AH, Jayakumar J, Schyns CJ, Yacoub MH. L-Arginine reverses low coronary reflow and enhances postischaemic recovery of cardiac mechanical function. Cardiovasc Res 1995;30:200-4.
13. 13. Amrani M, Gray C, Goodwin A, Smolenski RT, Marchbank A, Yacoub MH. Effects of L-arginine in cardioplegia and during reperfusion after prolonged cardioplegic arrest. Circulation 1996;94:671.
14. 14. Obadia JF, Giraud C, Ferrara R, Chuzel M, Chassognolle JF, Dureau G. Long conservation organs in heart transplantation: postoperative results and long-term follow-up in fourteen patients. J Heart Lung Transplant 1997;16:256-9.
15. 15. Kamelgard J, Crestanello JA, Fullerton D, Whitman GJ. Nitric oxide as a positive inotropic agent in isolated rat hearts. J Surg Res 1995;59:482-4.
16. 16. Ferdinandy P, Szilvassy Z, Csont T, et al. Nitroglycerin-induced direct protection of the ischaemic myocardium in isolated working hearts of rats with vascular tolerance to nitroglycerin. Br J Pharmacol 1995;115:1129-31.
17. 17. Paulus WJ, Vantrimpont PJ, Shah AM. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion. Circulation 1994;89:2070-8.
18. 18. Mohan P, Brutsaert DL, Paulus WJ, Sys SU. Myocardial contractile response to nitric oxide and cGMP. Circulation 1996;93:1223-9.
19. 19. Schulz R, Dodge KK, Lopaschuk GD, Clanachan AS. Peroxynitrite depresses cardiac efficiency in the isolated working heart. Am J Physiol 1997;272:H1212-9.
20. 20. Moro MA, Russel RJ, Cellek S, et al. cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc Natl Acad Sci USA 1996;93:1480-5.
21. 21. Wahler GM, Dollinger SJ. Nitric oxide donor SIN-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinase. Am J Physiol 1995;268:C45-54.
22. 22. Laustiola K, Vuorinen P, Vapaatalo H, Metsa-Ketela T. Sodium nitroprusside inhibits lactate formation in rat atria: is cyclic GMP involved? Acta Pharmacol Toxicol (Copenh) 1983;52:195-200.
23. 23. Finegan BA, Gandhi M, Lopaschuk GD, Clanachan AS. Antecedent ischemia reverses effects of adenosine on glycolysis and mechanical function of working hearts. Am J Physiol 1996;271:H2116-25.
24. 24. Liu B, Clanachan AS, Schulz R, Lopaschuk GD. Cardiac efficiency is improved after ischemia by altering both the source and fate of protons. Circ Res 1996;79:940-8.